Communicating with the FDA: the "third rail" of a new model for drug development

J Clin Pharmacol. 2008 Feb;48(2):144-5. doi: 10.1177/0091270007313560.
No abstract available

Publication types

  • Comment

MeSH terms

  • Clinical Trials as Topic / methods
  • Clinical Trials as Topic / standards
  • Drug Approval / legislation & jurisprudence*
  • Drug Approval / methods
  • Drug Approval / statistics & numerical data
  • Government Regulation*
  • Guidelines as Topic*
  • Humans
  • Interdisciplinary Communication
  • Investigational New Drug Application / legislation & jurisprudence
  • Investigational New Drug Application / methods
  • Investigational New Drug Application / statistics & numerical data
  • Legislation, Drug / standards
  • United States
  • United States Food and Drug Administration / legislation & jurisprudence*
  • United States Food and Drug Administration / organization & administration
  • United States Food and Drug Administration / standards